Science
Director of Quality Assurance
Last updated
Directors of Quality Assurance build and lead the quality management systems, audit programs, and regulatory compliance infrastructure that protect organizations from FDA and EMA enforcement actions. They oversee internal and vendor audits, manage inspection preparedness, write and enforce quality SOPs, and serve as the primary quality authority in interactions with health authorities.
Role at a glance
- Typical education
- Bachelor's degree in pharmacy, chemistry, biology, or engineering; Master's preferred
- Typical experience
- 15-20 years
- Key certifications
- RAC (Regulatory Affairs Certification), CQA (Certified Quality Auditor)
- Top employer types
- Pharmaceutical companies, biotech firms, medical device manufacturers, CDMOs, CROs
- Growth outlook
- Strong demand driven by expansion in biologics, cell/gene therapy, and increased manufacturing complexity
- AI impact (through 2030)
- Augmentation — AI-assisted tools are automating tactical tasks like deviation detection and root cause analysis, but human judgment remains critical for regulatory accountability and compliance evaluation.
Duties and responsibilities
- Design and maintain the organization's quality management system (QMS): SOPs, quality manual, CAPA infrastructure, and deviation management procedures
- Lead the internal audit program: schedule, scope, execute, and report on audits of clinical operations, laboratories, manufacturing sites, and vendors
- Manage vendor qualification audits for CROs, testing labs, and clinical suppliers; maintain the approved vendor/supplier list
- Direct FDA and EMA inspection preparedness: mock inspections, back-room team training, and document readiness programs
- Serve as the primary quality contact during regulatory inspections, managing the inspection team and coordinating the back-room response
- Review and approve quality-critical documents: audit reports, CAPA plans, deviation reports, and change control submissions
- Report quality metrics and compliance trends to executive leadership and the Board; advise on quality risk in program decisions
- Develop and lead the quality team: hire, mentor, and evaluate QA auditors and quality managers
- Manage the product complaint and post-market surveillance quality systems for approved products
- Partner with regulatory affairs on FDA warning letter responses, Form 483 response letters, and consent decree remediation programs
Overview
A Director of Quality Assurance is responsible for ensuring that the organization's regulated activities — clinical trials, manufacturing, laboratory testing — are conducted in compliance with FDA, EMA, and ICH requirements. When a health authority inspector arrives at the door, the QA Director is the person who has prepared for that visit and is primarily accountable for how it goes.
The QMS (Quality Management System) is the organizational framework the Director builds and maintains: SOPs that define how every regulated activity is performed, a CAPA system that captures and resolves quality problems, deviation management procedures that ensure departures from SOPs are documented and investigated, and training records that demonstrate every person performing regulated work has been trained and qualified to do it.
Audit execution is the most active ongoing function. Internal audits assess whether the organization's own procedures are being followed. Vendor audits assess whether CROs, testing labs, and clinical suppliers meet the organization's standards and applicable regulatory requirements. Audit findings go into reports, reports require responses and corrective actions, and corrective actions require follow-up to verify they actually worked. A QA function that audits but doesn't follow through on CAPAs provides false assurance.
Inspection preparedness is where QA Directors earn their salary. An FDA inspection is not pass/fail — it's a continuum from no findings to Warning Letter to consent decree. The difference between a clean inspection and a Form 483 with multiple observations is often attributable to the state of readiness the QA Director built before the inspection arrived. Mock inspections, document dry runs, back-room team training, and response protocols practiced in advance produce meaningfully better inspection outcomes.
Qualifications
Education:
- Bachelor's degree in pharmacy, chemistry, biology, or engineering required
- Master's degree in quality, regulatory affairs, or a life science preferred for Director-level roles
- RAC (Regulatory Affairs Certification) from RAPS is highly valued
- CQA (Certified Quality Auditor) from ASQ or industry equivalent
Experience:
- 15–20 years in pharmaceutical, biotech, or medical device quality roles
- Direct experience leading at least one FDA CGMP or BIMO inspection — front-room or back-room management
- CAPA system ownership and audit program management at the department level
- Vendor audit experience: conducting audits of CROs, CDMOs, or testing laboratories
- Warning letter response or consent decree remediation experience is a strong differentiator
Regulatory knowledge:
- GMP: 21 CFR Parts 210, 211 (drugs), 820 (devices), ICH Q7 (APIs), ICH Q10 (pharmaceutical quality system)
- GCP: 21 CFR Part 312, ICH E6(R3) for clinical quality audits
- GLP: 21 CFR Part 58 for non-clinical laboratory quality
- FDA 21 CFR Part 11 and EU Annex 11: computer systems validation requirements
- ICH Q9 (Quality Risk Management), Q10 (Pharmaceutical Quality System)
Systems and process knowledge:
- Electronic Quality Management Systems (eQMS): Veeva Vault QMS, TrackWise, MasterControl
- Computer system validation: GAMP 5 framework, UAT documentation, IQ/OQ/PQ protocols
- Change control processes: impact assessment, regulatory notification requirements
- SOP architecture: version control, periodic review cycles, approval workflows
Career outlook
Directors of Quality Assurance are essential to regulated industries, and demand for experienced QA leadership is consistently strong. Every pharmaceutical, biotech, and medical device company that operates in FDA-regulated markets needs a functioning quality system — it is not optional, and the penalty for a non-functioning one is severe: Warning Letters, consent decrees, plant shutdowns, and product recalls.
The life sciences industry's growth has expanded the total demand for QA leadership. More companies, more products, more manufacturing sites, and more clinical programs mean more quality oversight requirements. The GMP manufacturing segment in particular has seen significant investment in new biologics and cell and gene therapy facilities that require QA leadership to build quality systems from the ground up.
The talent market at Director level is tight. QA leadership is a specialized career path — not every quality professional accumulates the inspection management experience and regulatory breadth required for the Director title. Companies preparing for commercial manufacturing or approaching their first CGMP inspection are particularly aggressive in recruiting QA Directors with relevant experience.
The emergence of AI quality monitoring tools is changing the tactical work: automated deviation detection, AI-assisted CAPA root cause analysis, and document management AI are reducing the manual burden in quality systems. But the judgment required to evaluate whether a system is actually compliant — not just documented as compliant — remains a human function, and that judgment is what regulators hold QA Directors accountable for.
For QA Directors with GMP experience and manufacturing quality expertise, compensation at the VP level regularly exceeds $250K–$350K at large pharma and specialty manufacturing companies. The career path from Director to VP of Quality or Chief Quality Officer is well-established for those with multiple successful inspections and quality system builds in their track record.
Sample cover letter
Dear Hiring Manager,
I'm writing to apply for the Director of Quality Assurance position at [Company]. I currently serve as Senior QA Manager at [Company], where I have led the GCP and GMP quality programs for a mid-size clinical-stage biotech for the past five years. I've managed two FDA BIMO inspections (one surveillance, one bioresearch monitoring) and one EMA GMP inspection of our contract manufacturer during that time — all three closed without Warning Letters.
The work I'm most proud of is the CAPA system rebuild I led after joining [Company]. The existing system had 47 open CAPAs, 22 of them past their due dates, and no systematic tracking of whether closed CAPAs had actually resolved the original problem. I redesigned the CAPA workflow in our eQMS, implemented a monthly effectiveness check protocol, and drove the backlog to zero in eight months. The subsequent FDA inspection specifically noted our CAPA system as a strength.
I hold a RAC credential and a master's in pharmaceutical sciences, and I have direct experience writing FDA Form 483 responses and coordinating the corrective action commitments that follow. I'm also experienced in vendor audit management — I've conducted or led 14 audits of CROs and testing labs across three programs, with findings that have directly influenced our approved supplier list decisions.
I'm looking for a Director-level role at a company approaching commercial stage, where I can build out the GMP quality infrastructure needed to support a first NDA or BLA approval.
Thank you for your consideration.
[Your Name]
Frequently asked questions
- What background do most Directors of Quality Assurance have?
- Most have 15+ years in GCP, GMP, or GLP quality roles, having progressed from QA associate or auditor through QA manager and QA director. Scientific backgrounds in biology, chemistry, pharmacy, or engineering are common. Some come from regulatory affairs or clinical operations and transitioned to quality leadership. Experience with both sponsor and CRO environments is valued because it provides perspective on vendor audit standards.
- What is a CAPA system and why does it matter?
- CAPA stands for Corrective and Preventive Action — the formalized process by which organizations identify the root cause of quality problems, implement corrections, and take systemic actions to prevent recurrence. FDA 21 CFR Part 820 (devices), Part 211 (drugs), and ICH Q10 all require robust CAPA systems. Inspectors evaluate whether CAPAs are completing on time, addressing root cause, and working — a broken CAPA system is a significant inspection finding.
- What happens during an FDA inspection that a QA Director manages?
- FDA inspections (typically BIMO for clinical research or CGMP for manufacturing) involve investigators reviewing SOPs, records, equipment logs, and data systems on-site for 3–7 days. The QA Director typically manages the front room (accompanying investigators, routing requests) while a back-room team locates and reviews requested documents before providing them. At close, investigators issue a Form 483 with any observations; the Director drafts the company's written response within 15 business days.
- How has electronic systems validation changed QA requirements?
- FDA 21 CFR Part 11 and EU Annex 11 govern computerized systems used in regulated environments — EDC systems, LIMS, manufacturing systems. QA Directors must ensure that all computer systems used in regulated activities are properly validated, that audit trails are enabled and protected, and that access controls prevent unauthorized record changes. The validation burden has grown significantly as clinical and manufacturing operations digitize further.
- What is the difference between QA and QC?
- Quality Assurance (QA) focuses on the processes, systems, and audits that prevent quality problems — proactive and systemic. Quality Control (QC) focuses on testing and inspection of specific products or data to detect problems — reactive and specific. In pharma, QC includes laboratory testing of drug substance and product; QA includes the SOPs, training records, and audit trail management that ensure the lab operates in a validated, compliant manner.
More in Science
See all Science jobs →- Director of Clinical Research$150K–$220K
Directors of Clinical Research provide scientific and operational leadership for clinical development programs, overseeing the design, execution, and regulatory strategy for trials from Phase I through Phase IV. They lead cross-functional development teams, manage external research partnerships, and are accountable for the scientific integrity and regulatory success of their programs.
- Director of Regulatory Affairs$145K–$215K
Directors of Regulatory Affairs lead the strategy and execution of regulatory submissions, health authority interactions, and compliance programs for pharmaceutical, biologic, and medical device companies. They oversee INDs, NDAs, BLAs, 510(k)s, and post-approval programs, and serve as the primary expert interface with FDA, EMA, and other global health authorities.
- Director of Clinical Operations$155K–$225K
Directors of Clinical Operations own the infrastructure, people, and processes that execute clinical trials across an organization. They build and lead teams of study managers and project staff, establish quality systems and SOPs, manage CRO partnerships at the strategic level, and ensure the entire clinical operations function delivers trials on time and within budget.
- Document Control Specialist$50K–$80K
Document Control Specialists manage the lifecycle of controlled documents — standard operating procedures, work instructions, forms, and quality records — in regulated industries including pharmaceuticals, biotechnology, and medical devices. They ensure that the right document version is accessible to the right people, that retired versions are archived correctly, and that the document management system remains audit-ready.
- Clinical Trial Manager$90K–$132K
Clinical Trial Managers oversee the operational execution of one or more clinical trials, managing study startup, site networks, CRO performance, enrollment timelines, and data quality from protocol activation through database lock. They lead cross-functional study teams and are the primary accountability point for a trial's schedule, budget, and GCP compliance.
- Quality Assurance Auditor$68K–$108K
Quality Assurance Auditors assess whether pharmaceutical, biotech, and medical device manufacturing and laboratory operations conform to applicable GMP regulations, ISO standards, and internal quality system requirements. They conduct internal, supplier, and regulatory inspection readiness audits, document findings, track corrective actions, and help organizations maintain the compliance posture that protects product quality and patient safety.